Baxter International (NYSE:BAX) Issues Q1 2025 Earnings Guidance

Baxter International (NYSE:BAX - Get Free Report) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.470-0.500 for the period, compared to the consensus EPS estimate of 0.490. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $2.6 billion. Baxter International also updated its FY 2025 guidance to 2.450-2.550 EPS.

Baxter International Price Performance

Shares of Baxter International stock traded up $0.43 on Friday, hitting $33.87. 7,264,381 shares of the company traded hands, compared to its average volume of 4,927,193. The stock has a market capitalization of $17.29 billion, a P/E ratio of 169.33, a price-to-earnings-growth ratio of 9.83 and a beta of 0.61. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.09 and a current ratio of 1.43. Baxter International has a 52 week low of $28.33 and a 52 week high of $44.01. The business has a 50-day simple moving average of $30.65 and a 200 day simple moving average of $34.14.

Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.06. The firm had revenue of $2.75 billion for the quarter, compared to analysts' expectations of $2.67 billion. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. Research analysts expect that Baxter International will post 1.83 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Friday, February 28th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Friday, February 28th. Baxter International's payout ratio is currently 340.02%.

Analysts Set New Price Targets

BAX has been the topic of several recent analyst reports. Stifel Nicolaus reduced their price objective on shares of Baxter International from $46.00 to $38.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. Citigroup reduced their price target on shares of Baxter International from $37.00 to $35.00 and set a "neutral" rating on the stock in a research report on Wednesday, December 11th. Barclays started coverage on shares of Baxter International in a research report on Thursday. They issued an "overweight" rating and a $39.00 price target on the stock. StockNews.com cut shares of Baxter International from a "buy" rating to a "hold" rating in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Baxter International from $38.00 to $36.00 and set a "neutral" rating on the stock in a research report on Friday. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Baxter International currently has a consensus rating of "Hold" and an average target price of $38.80.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.